Literature DB >> 6805795

Intestinal permeability in children with Crohn's disease and coeliac disease.

A D Pearson, E J Eastham, M F Laker, A W Craft, R Nelson.   

Abstract

Mannitol and lactulose were used as probe molecules to measure intestinal permeability in children with active small-bowel Crohn's disease and with untreated coeliac disease. Mannitol and lactulose were administered by mouth in a moderately hypertonic solution (580 mmol (mosmol)/l), and results were expressed as the ratio of the molecules excreted in urine over five hours. Patients with Crohn's disease had a sixfold increase in permeability (due to increased lactulose permeability) and those with coeliac disease a fivefold increase (due to decreased mannitol permeability). From these results the test offers potential as a noninvasive investigation in children with small-bowel disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805795      PMCID: PMC1499105          DOI: 10.1136/bmj.285.6334.20

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  14 in total

1.  Definitions of inflammatory bowel disease of unknown etiology.

Authors:  H Schachter; J B Kirsner
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

2.  Route of passive ion permeation in epithelia.

Authors:  E Frömter; J Diamond
Journal:  Nat New Biol       Date:  1972-01-05

3.  Estimation of disaccharides in plasma and urine by gas-liquid chromatography.

Authors:  M F Laker
Journal:  J Chromatogr       Date:  1979-05-01

4.  Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease.

Authors:  I Cobden; R J Dickinson; J Rothwell; A T Axon
Journal:  Br Med J       Date:  1978-10-14

5.  Abnormal intestinal permeability to sugars in villous atrophy.

Authors:  I S Menzies; M F Laker; R Pounder; J Bull; S Heyer; P G Wheeler; B Creamer
Journal:  Lancet       Date:  1979-11-24       Impact factor: 79.321

6.  Water and solute movement in the small intestine of patients with sprue.

Authors:  J S Fordtran; F C Rector; T W Locklear; M F Ewton
Journal:  J Clin Invest       Date:  1967-03       Impact factor: 14.808

7.  Effect of hyperosmolar stimuli and coeliac disease on the permeability of the human gastrointestinal tract.

Authors:  P G Wheeler; I S Menzies; B Creamer
Journal:  Clin Sci Mol Med       Date:  1978-05

8.  Mannitol estimation in biological fluids by gas-liquid chromatography of trimethylsilyl derivatives.

Authors:  M F Laker; J N Mount
Journal:  Clin Chem       Date:  1980-03       Impact factor: 8.327

9.  Passage of molecules through the wall of the gastrointestinal tract. II. Application of low-molecular weight polyethyleneglycol and a deterministic mathematical model for determining intestinal permeability in man.

Authors:  T Sundqvist; K E Magnusson; R Sjödahl; I Stjernström; C Tagesson
Journal:  Gut       Date:  1980-03       Impact factor: 23.059

10.  Increase in human intestinal permeability following ingestion of hypertonic solutions.

Authors:  M F Laker; I S Menzies
Journal:  J Physiol       Date:  1977-03       Impact factor: 5.182

View more
  61 in total

1.  Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease.

Authors:  M A Cox; K O Lewis; B T Cooper
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

Review 2.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

Review 3.  Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Authors:  Lila G Glotfelty; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 4.  Tight junction pore and leak pathways: a dynamic duo.

Authors:  Le Shen; Christopher R Weber; David R Raleigh; Dan Yu; Jerrold R Turner
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

5.  Do non-steroidal anti-inflammatory drugs increase colonic permeability?

Authors:  A P Jenkins; D R Trew; B J Crump; W S Nukajam; J A Foley; I S Menzies; B Creamer
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

6.  Intestinal permeability barrier in Crohn's disease: the difficulty in shifting the paradigm.

Authors:  Daniel Hollander
Journal:  Dig Dis Sci       Date:  2013-06-08       Impact factor: 3.199

7.  Small bowel function in acute lymphoblastic leukaemia.

Authors:  A D Pearson; A W Craft; J V Pledger; E J Eastham; M F Laker; G L Pearson
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

8.  Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum.

Authors:  S Strobel; W G Brydon; A Ferguson
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

9.  Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.

Authors:  P Munkholm; E Langholz; D Hollander; K Thornberg; M Orholm; K D Katz; V Binder
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

10.  Zinc supplementation modifies tight junctions and alters barrier function of CACO-2 human intestinal epithelial layers.

Authors:  Xuexuan Wang; Mary Carmen Valenzano; Joanna M Mercado; E Peter Zurbach; James M Mullin
Journal:  Dig Dis Sci       Date:  2012-08-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.